These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10924736)

  • 21. Genetic factors play an important role in the pathogenesis of hyperlipidemia post-transplantation.
    Aguilar-Salinas CA; Díaz-Polanco A; Quintana E; Macias N; Arellano A; Ramírez E; Ordóñez ML; Velásquez-Alva C; Gómez Pérez FJ; Alberú J; Correa-Rotter R
    Am J Kidney Dis; 2002 Jul; 40(1):169-77. PubMed ID: 12087575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approach.
    Minicocci I; Prisco C; Montali A; Di Costanzo A; Ceci F; Pigna G; Arca M
    Atherosclerosis; 2015 Oct; 242(2):618-24. PubMed ID: 26342331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of insulin resistance, apoE2 allele, and smoking on combined hyperlipidemia.
    Sijbrands EJ; Westendorp RG; Hoffer MJ; Havekes LM; Frants RR; Meinders AE; Frölich M; Smelt AH
    Arterioscler Thromb; 1994 Oct; 14(10):1576-80. PubMed ID: 7918307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia.
    Rauh G; Schuster H; Müller B; Schewe S; Keller C; Wolfram G; Zöllner N
    Atherosclerosis; 1990 Jul; 83(1):81-7. PubMed ID: 1975179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carotid artery intima-media thickness in Finnish families with familial combined hyperlipidemia.
    Ylitalo K; Syvänne M; Salonen R; Nuotio I; Taskinen MR; Salonen JT
    Atherosclerosis; 2002 May; 162(1):171-8. PubMed ID: 11947911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common genetic variants contribute to primary hypertriglyceridemia without differences between familial combined hyperlipidemia and isolated hypertriglyceridemia.
    De Castro-Orós I; Cenarro A; Tejedor MT; Baila-Rueda L; Mateo-Gallego R; Lamiquiz-Moneo I; Pocoví M; Civeira F
    Circ Cardiovasc Genet; 2014 Dec; 7(6):814-21. PubMed ID: 25176936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
    Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.
    Deeb SS; Fajas L; Nemoto M; Pihlajamäki J; Mykkänen L; Kuusisto J; Laakso M; Fujimoto W; Auwerx J
    Nat Genet; 1998 Nov; 20(3):284-7. PubMed ID: 9806549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides.
    Coon H; Xin Y; Hopkins PN; Cawthon RM; Hasstedt SJ; Hunt SC
    Hum Genet; 2005 Sep; 117(5):444-51. PubMed ID: 15959806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of insulin resistance in familial combined hyperlipidemia.
    Veerkamp MJ; de Graaf J; Stalenhoef AF
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1026-31. PubMed ID: 15731490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus.
    Ringel J; Engeli S; Distler A; Sharma AM
    Biochem Biophys Res Commun; 1999 Jan; 254(2):450-3. PubMed ID: 9918859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial dyslipidemic hypertension syndrome: familial combined hyperlipidemia, and the role of abdominal fat mass.
    Keulen ET; Voors-Pette C; de Bruin TW
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):357-63. PubMed ID: 11336182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Pro12Ala PPARgamma2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men.
    Rosmond R; Chagnon M; Bouchard C
    Diabetes Metab Res Rev; 2003; 19(2):159-63. PubMed ID: 12673785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five-year follow-up of waist circumference, insulin and ALT levels in familial combined hyperlipidaemia.
    Brouwers MC; van Greevenbroek MM; Vermeulen VM; van Lin JM; van der Kallen CJ; de Bruin TW
    Clin Sci (Lond); 2007 Nov; 113(9):375-81. PubMed ID: 17564583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia.
    Geurts JM; Janssen RG; van Greevenbroek MM; van der Kallen CJ; Cantor RM; Bu X; Aouizerat BE; Allayee H; Rotter JI; de Bruin TW
    Hum Mol Genet; 2000 Sep; 9(14):2067-74. PubMed ID: 10958645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FABP4 plasma levels are increased in familial combined hyperlipidemia.
    Cabré A; Lázaro I; Cofán M; Jarauta E; Plana N; Garcia-Otín AL; Ascaso JF; Ferré R; Civeira F; Ros E; Masana L
    J Lipid Res; 2010 May; 51(5):1173-8. PubMed ID: 20388924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor gamma 2 Pro12Ala gene variant is strongly associated with larger body mass in the Taiwanese.
    Lei HH; Chen MH; Yang WS; Chiu MC; Chen MC; Tai TY; Chuang LM
    Metabolism; 2000 Oct; 49(10):1267-70. PubMed ID: 11079814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of chromosome 1q21-q23 to familial combined hyperlipidemia in Mexican families.
    Huertas-Vázquez A; del Rincón JP; Canizales-Quinteros S; Riba L; Vega-Hernández G; Ramírez-Jiménez S; Aurón-Gómez M; Gómez-Pérez FJ; Aguilar-Salinas CA; Tusié-Luna MT
    Ann Hum Genet; 2004 Sep; 68(Pt 5):419-27. PubMed ID: 15469419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
    Reynisdottir S; Eriksson M; Angelin B; Arner P
    J Clin Invest; 1995 May; 95(5):2161-9. PubMed ID: 7738184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.